Health@INNOHK
Centre for Oncology
and Immunology
Hidden risk factors for cancer in our day-to-day lives have an increasing global impact
The burden of cancer incidence and mortality is rapidly growing worldwide
But cancer cells have developed ways to resist current treatments
Cancer biomarkers are the future of precision-oncology
Our goal at COI is to use biotechnology and genomics to discover new biomarkers
that can be targeted for specific cancers
for precision medicine
COI aims to develop targeted therapeutics in immuno-oncology for cancers that are prevalent in Asia
and to establish Hong Kong as a leader in innovative anti-cancer R&D
scroll down
Health@INNOHK
Centre for Oncology and Immunology
Centre for Oncology and Immunology (COI) is co-directed by Professor Tak MAK and Professor Suet Yi LEUNG from HKUMed with the aim to develop innovative therapeutics in immuno-oncology for cancers that are prevalent in Asia and to establish Hong Kong as an international biotechnology hub for therapeutic development.
Visit Our Website
Co-Director
Professor Tak MAK
  • Professor, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • Professor, Department of Medical Biophysics and Department of Immunology, University of Toronto
  • Senior Staff Scientist, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Managing Director
Professor Suet Yi LEUNG
  • Head, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • Chair of Gastrointestinal Cancer Genetics and Genomics, Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • YW Kan Professor in Natural Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • Director, Centre for PanorOmics Sciences
HKU Innovation Holdings Ltd.
19/F, Kennedy Town Commercial Centre, 23 Belcher’s Street,
Kennedy Town, Hong Kong

Tel: 8652 9652
info@hkuinno.hk
© 2024 HKU Innovation Holdings Ltd.
About
R&D Centres
Gallery
News Centre
Useful Links
Contact